Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.

[1]  L. V. van't Veer,et al.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.

[2]  K. Kidwell,et al.  Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma. , 2015, American journal of clinical pathology.

[3]  Charles Swanton,et al.  Clinical management of breast cancer heterogeneity , 2015, Nature Reviews Clinical Oncology.

[4]  C. Sotiriou,et al.  Evolving paradigms in multifocal breast cancer. , 2015, Seminars in cancer biology.

[5]  Alessandro Neri,et al.  “Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases” , 2015, BMC Surgery.

[6]  L. Hutchinson.  Skin cancer: Golden age of melanoma therapy , 2015, Nature Reviews Clinical Oncology.

[7]  F. Cardoso,et al.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  G. Hortobagyi,et al.  Breast cancer multifocality and multicentricity and locoregional recurrence. , 2013, The oncologist.

[9]  R. Mansel,et al.  Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome. , 2013, European journal of cancer.

[10]  A. Bilici,et al.  The Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients: Single Center Experience , 2012, American journal of clinical oncology.

[11]  G. Hortobagyi,et al.  Multifocality and multicentricity in breast cancer and survival outcomes. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  S. Folli,et al.  Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  A. Giuliano,et al.  Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. , 2012, Journal of the American College of Surgeons.

[14]  Sung-Won Kim,et al.  The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. , 2012, Human pathology.

[15]  E. Rutgers,et al.  The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase. , 2011, European journal of cancer.

[16]  R. Rouzier,et al.  Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. , 2010, Surgical oncology.

[17]  T. Dimpfl,et al.  Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? , 2010, Breast Cancer Research and Treatment.

[18]  York Springer,et al.  Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .

[19]  Lajos Pusztai,et al.  Gene-expression signatures in breast cancer. , 2009, The New England journal of medicine.

[20]  Gregory Y. Lauwers,et al.  Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast , 2009 .

[21]  Ivo A. Olivotto,et al.  Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence , 2009, Breast Cancer Research and Treatment.

[22]  B. Rasmussen,et al.  Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001. , 2008, Breast.

[23]  Les Irwig,et al.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Wim H van Harten,et al.  Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). , 2007, The Lancet. Oncology.

[25]  Ritse M. Mann,et al.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.

[26]  P. Drew,et al.  Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer , 2007, Acta oncologica.

[27]  John Boyages,et al.  Multifocal and multicentric breast cancer: does each focus matter? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  B. Rasmussen,et al.  The prognostic influence of multifocality in breast cancer patients. , 2004, Breast.

[29]  B. Anderson,et al.  Trends in incidence rates of invasive lobular and ductal breast carcinoma. , 2003, JAMA.

[30]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.